Date:
Saturday, February 7, 2026
Time:
7:30AM - Registration/ Continental Breakfast
8:30AM - Program Starts
2:30PM - Program Concludes
Venue:
Loews Atlanta Hotel, 1065 Peachtree St. NE, Atlanta, GA 30309
Registration Fees:
Physician: $75
Nurse/Nurse Practitoner/Physician Assistant: $35
Resident/Fellow: $25
Industry: $300
Regional Directors:
Jane Meisel, MD
Kevin Kalinsky, MD
Preliminary Agenda
| Registration, Continental Breakfast, Exhibits Open | 7:30 AM - 8:30 AM |
| Welcome and Introduction of Program and Faculty Pre-Knowledge Assessment | 8:30 AM - 8:45 AM |
| New Directions in Breast Cancer Prevention and Approaches to Risk Reduction | 8:45 AM - 9:15 AM |
| Insights in Translational Research and Resistance Mechanisms | 9:15 AM - 9:45 AM |
| Biomarker Discoveries and Molecular Signatures | 9:45 AM - 10:15 AM |
| Panel Question and Answer Session | 10:15 AM - 10:30 AM |
| Refreshment Break with Exhibitors | 10:30 AM - 10:45 AM |
| Novel Therapeutics | 10:45 AM - 11:15 AM |
| Advances in Approaches to Local-Regional Disease (Surgical and Radiation) | 11:15 AM - 11:45 AM |
| Lunch Break and Supported Symposium - Exhibits Open | 11:45 AM - 12:45 PM |
| Updates in Early Breast Cancer | 12:45 PM - 1:15 PM |
| Updates in Management of Metastatic Disease | 1:15 PM - 1:45 PM |
| Panel Question and Answer Session | 1:45 PM - 2:00 PM |
| Clinical Controversies and Case Studies | 2:00 PM - 2:15 PM |
| Wrap-up and Post Test | 2:15 PM - 2:30 PM |
| Adjournment | 2:30 PM |
Program Overview
Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.
Learning Objectives
After participating in the Best of SABCS®️ program, learners will be able to:
1. INTERPRET recent advancements and research in breast cancer diagnosis, treatment, and specific considerations to enhance the care and outcomes of a diverse community of cancer patients.
2. LEVERAGE recent developments in the assessment and management of breast cancer subtypes to identify the most appropriate treatment strategies for people with breast cancer.
3. CONSTRUCT risk-adapted management strategies to optimize patient satisfaction, adherence, and treatment efficacy.
4. INTEGRATE new evidence from clinical trials in all aspects of breast cancer care presented during poster presentations and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice in order to improve patient care.
Target Audience
This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.
Accreditation Statement
The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide
continuing medical education for physicians.
The University of Texas at San Antonio has approved this program for AMA PRA Category 1 Credit™.
This Program is Supported with Educational Grants from:
AstraZeneca, Exact Sciences, Lilly, Novartis, and Stemline/Menarini
Interested in Exhibiting?
www.bestofsabcs.com/sponsorship